622 related articles for article (PubMed ID: 16293236)
21. Next generation OP-bioscavengers: a circulatory long-lived 4-PEG hypolysine mutant of F338A-HuAChE with optimal pharmacokinetics and pseudo-catalytic characteristics.
Kronman C; Cohen O; Mazor O; Ordentlich A; Raveh L; Velan B; Shafferman A
Chem Biol Interact; 2010 Sep; 187(1-3):253-8. PubMed ID: 20005217
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological agents in the prophylaxis/treatment of organophosphorous pesticide intoxication.
Husain K; Ansari RA; Ferder L
Indian J Exp Biol; 2010 Jul; 48(7):642-50. PubMed ID: 20929049
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of medical countermeasures against organophosphorus compounds: the value of experimental data and computer simulations.
Worek F; Aurbek N; Herkert NM; John H; Eddleston M; Eyer P; Thiermann H
Chem Biol Interact; 2010 Sep; 187(1-3):259-64. PubMed ID: 19917271
[TBL] [Abstract][Full Text] [Related]
24. Characterization of O,O-diethylphosphoryl oximes as inhibitors of cholinesterases and substrates of phosphotriesterases.
Leader H; Vincze A; Manisterski B; Rothschild N; Dosoretz C; Ashani Y
Biochem Pharmacol; 1999 Aug; 58(3):503-15. PubMed ID: 10424771
[TBL] [Abstract][Full Text] [Related]
25. Enzymes as pretreatment drugs for organophosphate toxicity.
Doctor BP; Raveh L; Wolfe AD; Maxwell DM; Ashani Y
Neurosci Biobehav Rev; 1991; 15(1):123-8. PubMed ID: 2052184
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of HI 6 treatment after percutaneous VR exposure by use of a kinetic-based dynamic computer model.
Aurbek N; Thiermann H; Szinicz L; Worek F
Toxicology; 2007 Apr; 233(1-3):173-9. PubMed ID: 16904808
[TBL] [Abstract][Full Text] [Related]
27. Cholinesterase reactivation in vivo with a novel bis-oxime optimized by computer-aided design.
Hammond PI; Kern C; Hong F; Kollmeyer TM; Pang YP; Brimijoin S
J Pharmacol Exp Ther; 2003 Oct; 307(1):190-6. PubMed ID: 12893843
[TBL] [Abstract][Full Text] [Related]
28. Structural approach to the aging of phosphylated cholinesterases.
Masson P; Nachon F; Lockridge O
Chem Biol Interact; 2010 Sep; 187(1-3):157-62. PubMed ID: 20338153
[TBL] [Abstract][Full Text] [Related]
29. Organophosphate-induced convulsions and prevention of neuropathological damages.
Tuovinen K
Toxicology; 2004 Mar; 196(1-2):31-9. PubMed ID: 15036754
[TBL] [Abstract][Full Text] [Related]
30. Estimation of oxime efficacy in nerve agent poisoning: a kinetic approach.
Worek F; Szinicz L; Thiermann H
Chem Biol Interact; 2005 Dec; 157-158():349-52. PubMed ID: 16266695
[TBL] [Abstract][Full Text] [Related]
31. Blood cholinesterases as human biomarkers of organophosphorus pesticide exposure.
Nigg HN; Knaak JB
Rev Environ Contam Toxicol; 2000; 163():29-111. PubMed ID: 10771584
[TBL] [Abstract][Full Text] [Related]
32. Human paraoxonase: a promising approach for pre-treatment and therapy of organophosphorus poisoning.
Rochu D; Chabrière E; Masson P
Toxicology; 2007 Apr; 233(1-3):47-59. PubMed ID: 17007987
[TBL] [Abstract][Full Text] [Related]
33. Testing of antidotes for organophosphorus compounds: experimental procedures and clinical reality.
Eyer P; Szinicz L; Thiermann H; Worek F; Zilker T
Toxicology; 2007 Apr; 233(1-3):108-19. PubMed ID: 17010492
[TBL] [Abstract][Full Text] [Related]
34. Simulated dermal contamination with capillary samples and field cholinesterase biomonitoring.
Yuknavage KL; Fenske RA; Kalman DA; Keifer MC; Furlong CE
J Toxicol Environ Health; 1997 May; 51(1):35-55. PubMed ID: 9169060
[TBL] [Abstract][Full Text] [Related]
35. Comparison of polyethylene glycol-conjugated recombinant human acetylcholinesterase and serum human butyrylcholinesterase as bioscavengers of organophosphate compounds.
Cohen O; Kronman C; Raveh L; Mazor O; Ordentlich A; Shafferman A
Mol Pharmacol; 2006 Sep; 70(3):1121-31. PubMed ID: 16801396
[TBL] [Abstract][Full Text] [Related]
36. Mutant acetylcholinesterases as potential detoxification agents for organophosphate poisoning.
Saxena A; Maxwell DM; Quinn DM; Radić Z; Taylor P; Doctor BP
Biochem Pharmacol; 1997 Jul; 54(2):269-74. PubMed ID: 9271331
[TBL] [Abstract][Full Text] [Related]
37. Organophosphate hydrolases as catalytic bioscavengers of organophosphorus nerve agents.
Trovaslet-Leroy M; Musilova L; Renault F; Brazzolotto X; Misik J; Novotny L; Froment MT; Gillon E; Loiodice M; Verdier L; Masson P; Rochu D; Jun D; Nachon F
Toxicol Lett; 2011 Sep; 206(1):14-23. PubMed ID: 21683774
[TBL] [Abstract][Full Text] [Related]
38. Optimization of Cholinesterase-Based Catalytic Bioscavengers Against Organophosphorus Agents.
Lushchekina SV; Schopfer LM; Grigorenko BL; Nemukhin AV; Varfolomeev SD; Lockridge O; Masson P
Front Pharmacol; 2018; 9():211. PubMed ID: 29593539
[TBL] [Abstract][Full Text] [Related]
39. Amino acid residues at the N- and C-termini are essential for the folding of active human butyrylcholinesterase polypeptide.
Naik RS; Pattabiraman N; Patel KA; Doctor BP; Saxena A
Chem Biol Interact; 2013 Mar; 203(1):24-9. PubMed ID: 23044488
[TBL] [Abstract][Full Text] [Related]
40. The use of cholinesterases in ecotoxicology.
Nunes B
Rev Environ Contam Toxicol; 2011; 212():29-59. PubMed ID: 21432054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
